Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7518-7524

  Tomioka, Daisaku ^a   Maehara, Naoki ^b   Kuba, Keiji ^a   Mizumoto, Kazuhiro ^b   Tanaka, Masao ^b   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NK 4; RECOMBINANT PROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KRINGLE DOMAIN; METASTASIS; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DISEASE PROGRESSION; GROWTH INHIBITORS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MITOGENS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035887435     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Treatment and survival in 13.560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study
2. The National Cancer Database report on pancreatic cancer
3. Pancreatic carcinoma
4. Pancreatic carcinoma in perspective. A continuing challenge
5. Biology of pancreatic cancer
6. A white paper: The product of a pancreas cancer think tank
7. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
8. Molecular cloning and expression of human hepatocyte growth factor
9. Met-HGF/SF: Tumorigenesis, invasion and metastasis
10. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions
11. Hepatocyte growth factor/scatter factor: Its molecular, cellular and clinical implications in cancer
12. HGF-c-Met receptor pathway in tumor invasion-metastasis and potential cancer treatment with NK4
13. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer
14. Hepatocyte growth factor is a potent mitogen for normal human pancreas cells in vitro
15. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
16. c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth
17. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met
18. The molecular and cellular biology of pancreatic cancer
19. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
20. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer
21. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
22. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor
23. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4
24. NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells
25. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice
26. Angiogenesis in cancer, vascular, rheumatoid and other disease
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. Reciprocal balance of hepatocyte growth factor and transforming growth factor-β in renal fibrosis in mice
29. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
30. Orthotopic xenografts of human pancreatic caminomas acquire genetic aberrations during dissemination in nude mice
31. Orthotopic models of human pancreatic cancer
32. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells
33. Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis
34. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo
35. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
36. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
37. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells
38. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis